MiMedx Group, Inc (MDXG) Stock Price

MDXGStock

$4.43−33.18%52W

Market Cap$646.49M

P/E13.29x

PEG Ratio2.88

Div yield—

Beta1.20

MDXG Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)3.10%

Price vs S&P 500 (4W)-6.58%

PEG Ratio2.88

VGM Score47.72

P/E Ratio (Annual)13.29x

P/CF (Annual)8.73x

Book Value / Share (Quarterly)$1.48

P/TBV (Annual)4.14x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)16.06%

Cash Flow / Share (Quarterly)$0.30

Price vs S&P 500 (YTD)-46.49%

Gross Margin (TTM)78.85%

Net Profit Margin (TTM)1.76%

EPS (TTM)$0.04

10-Day Avg Trading Volume1.15M

EPS Excl Extra (TTM)$0.04

Revenue Growth (5Y)11.02%

EPS (Annual)$0.32

ROI (Annual)17.70%

Gross Margin (Annual)82.56%

Net Profit Margin (5Y Avg)5.32%

Cash / Share (Quarterly)$0.93

P/E Basic Excl Extra (TTM)103.50x

Revenue Growth QoQ (YoY)-34.73%

P/E Normalized (Annual)13.29x

ROA (Last FY)14.18%

Revenue Growth TTM (YoY)-2.36%

EBITD / Share (TTM)$0.06

ROE (5Y Avg)6.01%

Operating Margin (TTM)2.46%

Cash Flow / Share (Annual)$0.49

P/B Ratio2.99x

P/B Ratio (Quarterly)2.65x

Net Income / Employee (Annual)$60,100

EV / Revenue (TTM)1.48x

Net Interest Coverage (TTM)77.70x

ROA (TTM)1.99%

EPS Growth QoQ (YoY)103.21%

EV / EBITDA (TTM)55.00x

EPS Incl Extra (Annual)$0.32

Current Ratio (Annual)4.32x

Quick Ratio (Quarterly)4.79x

3-Month Avg Trading Volume1.25M

52-Week Price Return-33.18%

EV / Free Cash Flow (Annual)7.22x

P/E Incl Extra (TTM)103.50x

Revenue / Employee (TTM)$439,600

Tangible BV / Share (Quarterly)$1.40

P/S Ratio (Annual)1.54x

Asset Turnover (Annual)1.22x

52-Week High$7.97

Operating Margin (5Y Avg)6.48%

EPS Excl Extra (Annual)$0.32

CapEx CAGR (5Y)-25.69%

Tangible BV CAGR (5Y)23.20%

26-Week Price Return13.01%

Quick Ratio (Annual)3.92x

13-Week Price Return3.02%

Total Debt / Equity (Annual)0.07x

Current Ratio (Quarterly)5.33x

Enterprise Value$527.09M

Revenue / Share Growth (5Y)4.06%

Asset Turnover (TTM)1.14x

Book Value / Share Growth (5Y)16.02%

Revenue / Employee (Annual)$518,100

Inventory Turnover (Annual)2.97x

Pretax Margin (Annual)15.83%

Cash / Share (Annual)$1.12

3-Month Return Std Dev31.63%

Gross Margin (5Y Avg)82.71%

Net Income / Employee (TTM)$7,700

ROE (Last FY)18.94%

Net Interest Coverage (Annual)8.59x

EPS Basic Excl Extra (Annual)$0.32

P/FCF (TTM)9.32x

Receivables Turnover (TTM)6.43x

EV / Free Cash Flow (TTM)11.86x

Total Debt / Equity (Quarterly)0.08x

EPS Incl Extra (TTM)$0.04

Receivables Turnover (Annual)6.37x

ROI (TTM)2.43%

P/S Ratio (TTM)1.82x

Pretax Margin (5Y Avg)5.34%

Revenue / Share (Annual)$2.80

Tangible BV / Share (Annual)$1.64

Forward P/E364.19x

Price vs S&P 500 (52W)-48.71%

P/E Ratio (TTM)103.50x

EPS Growth TTM (YoY)-81.69%

Year-to-Date Return-34.56%

5-Day Price Return-8.28%

EPS Normalized (Annual)$0.32

ROA (5Y Avg)6.30%

Net Profit Margin (Annual)11.60%

Month-to-Date Return-4.94%

Cash Flow / Share (TTM)$0.01

EBITD / Share (Annual)$0.44

Operating Margin (Annual)15.26%

LT Debt / Equity (Annual)0.06x

P/CF (TTM)13.99x

ROI (5Y Avg)7.24%

P/E Excl Extra (TTM)103.50x

LT Debt / Equity (Quarterly)0.07x

EPS Basic Excl Extra (TTM)$0.04

P/TBV (Quarterly)2.81x

P/B Ratio (Annual)3.91x

Inventory Turnover (TTM)3.28x

Pretax Margin (TTM)3.25%

Book Value / Share (Annual)$1.73

Price vs S&P 500 (13W)0.34%

Beta1.20x

P/FCF (Annual)8.85x

Revenue / Share (TTM)$2.40

ROE (TTM)2.61%

52-Week Low$3.03

vGradeC

gGradeD

mGradeC

vgmGradeC

MDXG Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Jul 29, 2026	-$0.03	-$0.05	-50.02%(-$0.02)
Q1 2026	Apr 29, 2026	-$0.04	-$0.05	-33.33%(-$0.01)
Q4 2025	Feb 25, 2026	$0.11	$0.14	+30.23%(+$0.03)
Q3 2025	Oct 29, 2025	$0.07	$0.15	+100.00%(+$0.08)
Q2 2025	Jul 30, 2025	$0.06	$0.10	+81.82%(+$0.05)

MDXG Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.08

4.09

Industry Peers — Surgical & Medical Instruments(142)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
MDXGMiMedx Group, Inc	C	D	C	1.8x	11.0%	78.8%	2.5%	$4.43
SYKStryker Corporation	C	B	C	4.4x	11.8%	65.3%	21.3%	$294.66
MMM3M Company	C	D	B	3.4x	-5.0%	39.4%	18.4%	$164.75
BSXBoston Scientific Corp.	C	B	C	3.1x	15.2%	69.5%	19.8%	$44.39
BDXBecton, Dickinson and Co.	B	D	A	2.5x	6.3%	46.7%	9.6%	$191.75
MDLNMedline Inc. Class A common stock	C	D	C	1.6x	—	26.2%	6.0%	$35.96
RMDResMed Inc.	C	C	B	5.9x	12.1%	61.1%	33.4%	$238.97
DXCMDexCom, Inc.	C	B	B	6.5x	19.3%	64.3%	22.9%	$86.04
WSTWest Pharmaceutical Services, Inc.	D	C	A	8.5x	7.4%	36.8%	20.4%	$384.02
SOLVSolventum Corporation	C	C	B	1.8x	—	54.8%	23.9%	$85.81
BAXBaxter International Inc.	B	D	B	1.1x	-0.8%	30.7%	-2.3%	$25.28
PENPenumbra, Inc.	F	C	B	8.4x	20.2%	67.8%	12.4%	$320.86
GMEDGLOBUS MEDICAL INC	B	B	B	3.3x	30.1%	68.5%	20.6%	$76.71
PODDInsulet Corporation	C	A	C	3.2x	24.5%	71.1%	16.9%	$141.10
GKOSGlaukos Corporation	F	A	B	15.9x	17.7%	79.1%	-31.6%	$164.84
TFXTeleflex Incorporated	B	F	B	2.1x	-4.7%	53.8%	-11.7%	$130.43
HAEHaemonetics Corporation	C	C	A	4.0x	8.9%	59.1%	11.9%	$118.28
MMSIMerit Medical Systems Inc	C	B	B	3.4x	9.5%	49.5%	12.8%	$89.20
STVNStevanato Group S.p.A.	D	C	C	3.7x	12.4%	29.9%	16.4%	$18.90
MMEDMiniMed Group, Inc. Common Stock	—	—	B	—	—	—	—	$17.49
HTFLHeartflow, Inc. Common Stock	F	A	A	19.8x	—	80.1%	-40.8%	$48.29
ICUIICU Medical Inc	C	D	B	1.9x	11.9%	39.1%	3.5%	$162.99
IRTCiRhythm Holdings, Inc. Common Stock	D	B	C	4.3x	23.0%	71.5%	-3.0%	$108.66
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	2725.9x	—	0.3%	-7007.8%	$44.43
ATRCAtriCure, Inc.	D	B	A	5.0x	20.9%	76.3%	2.3%	$56.07
UFPTUFP Technologies Inc	C	B	A	3.6x	27.4%	28.5%	15.3%	$291.67
INSPInspire Medical Systems, Inc.	B	B	B	2.2x	51.2%	86.1%	6.0%	$68.79
LMATLeMaitre Vascular, Inc.	C	B	C	7.0x	14.0%	72.9%	29.5%	$80.82
NVCRNovoCure Limited Ordinary Shares	D	C	C	2.3x	5.8%	76.1%	-22.1%	$14.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	15.2x	—	53.9%	-140.4%	$27.24
ATECAlphatec Holdings, Inc.	D	B	C	2.0x	39.5%	70.8%	-7.5%	$10.46
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	B	—	—	—	—	$12.29
TNDMTandem Diabetes Care, Inc.	D	C	C	1.1x	15.3%	56.0%	-4.4%	$16.24
IRMDiRadimed Corporation	D	B	B	13.1x	21.4%	75.9%	31.9%	$88.27
AORTArtivion, Inc.	C	C	C	2.3x	11.8%	64.4%	2.9%	$21.78
IARTIntegra LifeSciences Holdings	B	F	C	0.6x	3.6%	57.2%	4.0%	$13.21
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	3.0x	109.0%	64.2%	-33.9%	$17.57
BVSBioventus Inc. Class A Common Stock	B	C	A	1.9x	12.1%	68.7%	10.0%	$13.30
BBNXBeta Bionics, Inc. Common Stock	D	A	C	7.4x	—	58.3%	-69.8%	$16.35
SIBNSI-BONE, Inc. Common Stock	D	B	B	4.1x	22.3%	79.5%	-8.3%	$19.68
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	—	—	—	—	$24.00
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	2.3x	27.2%	73.7%	-11.9%	$21.95
TCMDTactile Systems Technology, Inc.	B	B	B	1.5x	12.0%	51.9%	10.0%	$22.52
SSIISS Innovations International Inc. Common Stock	F	A	D	9.7x	—	47.6%	-16.2%	$2.53
DCTHDelcath Systems Inc	D	C	B	5.1x	120.1%	87.0%	-1.9%	$14.08
ANGOAngioDynamics, Inc.	C	D	C	1.5x	1.9%	55.6%	-11.2%	$11.24
BWAYBrainsway Ltd. American Depositary Shares	D	B	B	9.5x	12.2%	74.9%	5.8%	$11.44
SGHTSight Sciences, Inc. Common Stock	D	B	A	5.5x	22.9%	88.4%	-33.4%	$8.28
CERSCerus Corp	D	C	C	1.8x	15.4%	57.2%	-0.7%	$2.18
NPCENeuropace, Inc. Common Stock	D	C	C	4.3x	19.4%	79.6%	-15.3%	$12.24
RCELAvita Medical, Inc. Common Stock	D	C	A	5.3x	19.6%	82.1%	-46.6%	$13.04

About MiMedx Group, Inc

MiMedx Group develops regenerative biomaterial products derived from human amniotic membrane and birth tissues for wound care, surgical, burn, orthopedic, and sports medicine applications. The company's core offerings include EpiFix and AmnioFix, flagship allografts that address external and internal wound healing needs across multiple surgical specialties. MiMedx also generates revenue through licensed partnerships for ophthalmic and dental applications.

MDXG Next Earnings Report

Report dateOct 28, 2026

QuarterQ3 2026

Report timeAMC

EPS estimate$0.00

Revenue estimate$68.72M

Also reporting on Oct 28, 2026

Scheduled date with consensus estimates — both can change before the company reports.

Earnings calendar for October 2026

Companies in Related Industries

FEIMFrequency Electronics, Inc.Instruments for Measuring
MOVMovado Group, Inc.Watches & Clocks
MLABMesa Laboratories IncIndustrial Instruments
CTKBCytek Biosciences, Inc. Common StockLab Analytical Instruments
AVRAnteris Technologies Global Corp. Common StockOrthopedic & Prosthetic Devices
PACBPacific Biosciences of California, Inc.Lab Analytical Instruments
MASS908 Devices Inc. Common StockLab Analytical Instruments
SENSSenseonics Holdings, Inc. Common StockIndustrial Instruments

Same SIC sector, outside this company's own industry.

Analyst Sentiment

4.1

Buy

Consensus rating

52-Week Range

Low$3.03

High$7.97